ClinicalTrials.Veeva

Menu

Evaluation of the Frequency of Limitation of Activity in Patients With Persistent Asthma (ASMAVIE)

AstraZeneca logo

AstraZeneca

Status

Completed

Conditions

Persistent Asthma

Study type

Observational

Funder types

Industry

Identifiers

NCT01078688
NIS-RFR-DUM-2009/2

Details and patient eligibility

About

Evaluation of the frequency of limitation of activity, depending on gender and age-group, in patients with persistent asthma consulting a general practitioner

Enrollment

1,942 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • persistent asthma receiving long-term maintenance treatment with inhaled steroids (alone or in combination with other drugs)

Exclusion criteria

  • Patients with a diagnosis of COPD

Trial contacts and locations

728

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems